Literature DB >> 24899712

BDNF signaling in the VTA links the drug-dependent state to drug withdrawal aversions.

Hector Vargas-Perez1, Amine Bahi2, Mary Rose Bufalino3, Ryan Ting-A-Kee4, Geith Maal-Bared4, Jenny Lam4, Ahmed Fahmy4, Laura Clarke4, Jennifer K Blanchard5, Brett R Larsen5, Scott Steffensen5, Jean-Luc Dreyer6, Derek van der Kooy7.   

Abstract

Drug administration to avoid unpleasant drug withdrawal symptoms has been hypothesized to be a crucial factor that leads to compulsive drug-taking behavior. However, the neural relationship between the aversive motivational state produced by drug withdrawal and the development of the drug-dependent state still remains elusive. It has been observed that chronic exposure to drugs of abuse increases brain-derived neurotrophic factor (BDNF) levels in ventral tegmental area (VTA) neurons. In particular, BDNF expression is dramatically increased during drug withdrawal, which would suggest a direct connection between the aversive state of withdrawal and BDNF-induced neuronal plasticity. Using lentivirus-mediated gene transfer to locally knock down the expression of the BDNF receptor tropomyosin-receptor-kinase type B in rats and mice, we observed that chronic opiate administration activates BDNF-related neuronal plasticity in the VTA that is necessary for both the establishment of an opiate-dependent state and aversive withdrawal motivation. Our findings highlight the importance of a bivalent, plastic mechanism that drives the negative reinforcement underlying addiction.
Copyright © 2014 the authors 0270-6474/14/347899-11$15.00/0.

Entities:  

Keywords:  BDNF; TrkB; dependent state; drug addiction; opiates; withdrawal

Mesh:

Substances:

Year:  2014        PMID: 24899712      PMCID: PMC4099491          DOI: 10.1523/JNEUROSCI.3776-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  33 in total

Review 1.  Neurobiology of addiction.

Authors:  R A Wise
Journal:  Curr Opin Neurobiol       Date:  1996-04       Impact factor: 6.627

Review 2.  Neurobiological constraints on behavioral models of motivation.

Authors:  K Nader; A Bechara; D van der Kooy
Journal:  Annu Rev Psychol       Date:  1997       Impact factor: 24.137

3.  Drug abuse: hedonic homeostatic dysregulation.

Authors:  G F Koob; M Le Moal
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

Review 4.  Cellular and molecular mechanisms of drug dependence.

Authors:  G F Koob; F E Bloom
Journal:  Science       Date:  1988-11-04       Impact factor: 47.728

5.  Neurobiology of withdrawal motivation: evidence for two separate aversive effects produced in morphine-naive versus morphine-dependent rats by both naloxone and spontaneous withdrawal.

Authors:  A Bechara; K Nader; D van der Kooy
Journal:  Behav Neurosci       Date:  1995-02       Impact factor: 1.912

Review 6.  Stressor-induced anhedonia in the mesocorticolimbic system.

Authors:  R M Zacharko; H Anisman
Journal:  Neurosci Biobehav Rev       Date:  1991       Impact factor: 8.989

7.  Opiate state controls bi-directional reward signaling via GABAA receptors in the ventral tegmental area.

Authors:  Steven R Laviolette; Roger A Gallegos; Steven J Henriksen; Derek van der Kooy
Journal:  Nat Neurosci       Date:  2004-01-18       Impact factor: 24.884

8.  Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse.

Authors:  Nobuaki Tamamaki; Yuchio Yanagawa; Ryohei Tomioka; Jun-Ichi Miyazaki; Kunihiko Obata; Takeshi Kaneko
Journal:  J Comp Neurol       Date:  2003-12-01       Impact factor: 3.215

Review 9.  Neural substrates of opiate withdrawal.

Authors:  G F Koob; R Maldonado; L Stinus
Journal:  Trends Neurosci       Date:  1992-05       Impact factor: 13.837

Review 10.  Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence.

Authors:  G F Koob; L Stinus; M Le Moal; F E Bloom
Journal:  Neurosci Biobehav Rev       Date:  1989 Summer-Fall       Impact factor: 8.989

View more
  21 in total

1.  Microglia disrupt mesolimbic reward circuitry in chronic pain.

Authors:  Anna M W Taylor; Annie Castonguay; Alison J Taylor; Niall P Murphy; Atefeh Ghogha; Christopher Cook; Lihua Xue; Mary C Olmstead; Yves De Koninck; Christopher J Evans; Catherine M Cahill
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

2.  Expression of the μ, κ, and δ-opioid receptors and tyrosine hydroxylase in MN9D cells.

Authors:  Pengxiang Tian; Weibo Shi; Jie Liu; Jie Wang; Chunling Ma; Qian Qi; Bin Cong; Yingmin Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  H4K5 histone acetylation of BRG1 is associated with heroin administration rather than addiction.

Authors:  Limin Xu; Qingxiao Hong; Xiaoying Chen; Xuting Xu; Huifen Liu; Wenhua Zhou; Shiwei Duan
Journal:  Exp Ther Med       Date:  2016-07-13       Impact factor: 2.447

4.  Deletion of α5 nicotine receptor subunits abolishes nicotinic aversive motivational effects in a manner that phenocopies dopamine receptor antagonism.

Authors:  Taryn E Grieder; Olivier George; Mandy Yee; Michael A Bergamini; Michal Chwalek; Geith Maal-Bared; Hector Vargas-Perez; Derek van der Kooy
Journal:  Eur J Neurosci       Date:  2017-06-21       Impact factor: 3.386

5.  Brain-derived neurotrophic factor and addiction: Pathological versus therapeutic effects on drug seeking.

Authors:  Jacqueline M Barker; Jane R Taylor; Taco J De Vries; Jamie Peters
Journal:  Brain Res       Date:  2014-11-04       Impact factor: 3.252

Review 6.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

Review 7.  Inhibitory Plasticity of Mesocorticolimbic Circuits in Addiction and Mental Illness.

Authors:  Alexey Ostroumov; John A Dani
Journal:  Trends Neurosci       Date:  2018-08-24       Impact factor: 13.837

Review 8.  Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation.

Authors:  Catherine M Cahill; Wendy Walwyn; Anna M W Taylor; Amynah A A Pradhan; Christopher J Evans
Journal:  Trends Pharmacol Sci       Date:  2016-09-23       Impact factor: 14.819

9.  Elevated methylation and decreased serum concentrations of BDNF in patients in levomethadone compared to diamorphine maintenance treatment.

Authors:  Rilana Schuster; Alexandra Kleimann; Marie-Kathrin Rehme; Leonie Taschner; Alexander Glahn; Adrian Groh; Helge Frieling; Ralf Lichtinghagen; Thomas Hillemacher; Stefan Bleich; Annemarie Heberlein
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-01-22       Impact factor: 5.270

10.  Formation of aversive memories associated with conditioned drug withdrawal requires BDNF expression in the amygdala in acute morphine-dependent rats.

Authors:  Yun-yue Ju; Jian-dong Long; Yao Liu; Jing-gen Liu
Journal:  Acta Pharmacol Sin       Date:  2015-11-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.